Here's where Merck's new Cambridge research facility will be located

The 50,000-square-foot space is in the building of a company Merck acquired in 2014.

Pharma's heavy hitters back Mass. partnership targeting Alzheimer’s

The decision to single out Alzheimer’s among all possible diseases is based on the utter lack of current treatments as well as the growing prevalence of the problem.

​How Harvard Bioscience deals with the pros and cons of its own name

Today the Holliston company is one of a handful of for-profit firms authorized to do business using the coveted name of the world’s most famous university.

Third Rock startup Decibel makes noise by naming Biogen exec as CEO

Steve Holtzman has a personal connection to hearing loss, saying, “I’m one of the baby boomers who doesn’t hear as well as he used to, has trouble deciphering speech and noise.”

Alere recall may further complicate proposed merger with Abbott Labs

Zika cases in Mass. climb to 39 as testing proves a challenge

Dana-Farber expanding research space in Longwood medical area

Imprivata will be taken private in $544M deal

Boston Business Journal Science & Tech Newsletters